首页> 美国卫生研究院文献>Einstein >Transfusion-related acute lung injury associated to intravenous immunoglobulin infusion in a pediatric patient
【2h】

Transfusion-related acute lung injury associated to intravenous immunoglobulin infusion in a pediatric patient

机译:与静脉内免疫球蛋白输注在儿科患者中相关的输血相关的急性肺损伤

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Case report of a patient with an immunodeficiency who demands regular replacement of intravenous immunoglobulin. She presented an episode of transfusion-related acute lung injury shortly after using an immunoglobulin product different than the one she usually received. The patient evolved with respiratory changes (hypoxia, dyspnea, change in pulmonary auscultation) minutes after the end of the infusion, and received non-invasive respiratory support. She was discharged after 36 hours with good outcome. The patient achieved full recovery, showing no further reactions in subsequent immunoglobulin infusions (no longer receiving the product that was used when she had the episode of transfusion-related acute lung injury). Although rare, this reaction is potentially serious and has no specific treatment other than supportive therapy. The literature is scarce regarding the risk of recurrence. The decision on whether to proceed with immunoglobulin therapy after this adverse effect should be analyzed individually, assessing the possible risks and benefits for the patient.
机译:具有免疫缺陷的患者的病例报告,要求定期替代静脉内免疫球蛋白。使用与通常收到的免疫球蛋白产物不同,她在使用不同的免疫球蛋白产品后不久介绍了输血相关急性肺损伤的一集。患者随着呼吸变化(缺氧,呼吸困难,肺功能变化)进化,输注结束后分钟,并接受非侵入性呼吸载体。 36小时后,她在良好的结果之后出院。患者达到全面恢复,显示出在随后的免疫球蛋白输注中没有进一步的反应(不再接受当患有输血相关的急性肺损伤事件时使用的产物)。虽然罕见,但这种反应可能是严重的,并且除了支持性疗法之外没有具体治疗。文献对复发的风险稀缺。应单独分别分析在这种不利影响后是否进行免疫球蛋白治疗的决定,评估患者可能的风险和益处。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号